Results 191 to 200 of about 28,400 (289)

Nipple Is Not Elevated with Breast Augmentation

open access: yesPlastic and Reconstructive Surgery - Global Open, 2016
Anna A. Borovikova   +2 more
openaire   +3 more sources

Biocompatible Mesoporous Materials for Bone Therapy

open access: yesAdvanced Science, EarlyView.
Biocompatible mesoporous materials (BMMs), characterized by high specific surface area, tunable pore size, different shapes and structures, and multidimensional functionalized modifications, have revolutionary applications in treating bone‐related diseases.
Biao Yu   +6 more
wiley   +1 more source

Polyphenol‐Based Functional Materials: Structural Insights, Composite Strategies, and Biomedical Applications

open access: yesAdvanced Science, EarlyView.
This schematic representation illustrates the interaction mechanisms between polyphenolic compounds and various materials (metals, proteins, polysaccharides, alkaloids, etc.). And explains the potential clinical application value of these materials (nanoparticles, coatings, films, capsules, and hydrogels constructed using polyphenols) in the fields of ...
Songwen Xue   +6 more
wiley   +1 more source

Treatment of the Hypertrophic Nipple in Breast Augmentation. [PDF]

open access: yesPlast Surg (Oakv)
Olivera Whyte LM   +2 more
europepmc   +1 more source

An Ultra‐Selective and Humidity‐Resistant Room‐Temperature‐Operated NO2 Sensor Based on Black TiO2

open access: yesAdvanced Science, EarlyView.
A room‐temperature‐operated NO2 sensor that achieves ultrahigh selectivity and humidity resistance is developed using black TiO2 for the first time in this work. A portable sensing equipment capable of recognizing NO2 from a mixed atmosphere with several common interfering gases and identifying real environmental differences is developed ...
Xuelan Cheng   +10 more
wiley   +1 more source

In Situ Vaccines in the Era of Cancer Immunotherapy: Conceptual Innovation and Clinical Translation

open access: yesAdvanced Science, EarlyView.
In this review, the basic concepts of in situ vaccination are discussed, its advantages over conventional vaccines, and key historical milestones, from the first use of Coley's toxins to the most recent FDA‐approved in situ vaccine for bladder cancer.
Yiru Shi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy